fruquintinib

fruquintinib (FRUZAQLA) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda. Route of administration: oral. Current US regulatory status: approved.

FRUZAQLA is a marketed brand name for fruquintinib. Check FDA Drugs@FDA for the current US label holder and prescribing information.

fruquintinib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.